Compare, Analyse IPCA Labs with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs TEVA PHARMA (Israel) - Comparison Results

IPCA LABS     Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   TEVA PHARMA
EQUITY SHARE DATA
    IPCA LABS
Mar-19
TEVA PHARMA
Dec-13
IPCA LABS/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0423,119-   
Low Rs5902,710-   
Sales per share (Unadj.) Rs298.61,790.2-  
Earnings per share (Unadj.) Rs35.0111.8-  
Cash flow per share (Unadj.) Rs49.4256.5-  
Dividends per share (Unadj.) Rs3.0097.90-  
Dividend yield (eoy) %0.43.4 10.9%  
Book value per share (Unadj.) Rs247.11,988.5-  
Shares outstanding (eoy) m126.35848.00-   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x2.71.6 167.8%   
Avg P/E ratio x23.326.1 89.5%  
P/CF ratio (eoy) x16.511.4 145.3%  
Price / Book Value ratio x3.31.5 225.3%  
Dividend payout %8.687.5 9.8%   
Avg Mkt Cap Rs m103,1082,471,471 4.2%   
No. of employees `00013.444.9 29.9%   
Total wages/salary Rs m7,8740-   
Avg. sales/employee Rs Th2,807.033,776.1 8.3%   
Avg. wages/employee Rs Th585.80-   
Avg. net profit/employee Rs Th329.02,110.0 15.6%   
INCOME DATA
Net Sales Rs m37,7321,518,065 2.5%  
Other income Rs m5770-   
Total revenues Rs m38,3091,518,065 2.5%   
Gross profit Rs m6,901415,723 1.7%  
Depreciation Rs m1,824122,707 1.5%   
Interest Rs m18929,817 0.6%   
Profit before tax Rs m5,465263,199 2.1%   
Minority Interest Rs m01,196 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-172,776 0.0%   
Tax Rs m1,042-3,213 -32.4%   
Profit after tax Rs m4,42294,832 4.7%  
Gross profit margin %18.327.4 66.8%  
Effective tax rate %19.1-1.2 -1,562.4%   
Net profit margin %11.76.2 187.6%  
BALANCE SHEET DATA
Current assets Rs m23,7781,025,296 2.3%   
Current liabilities Rs m10,975894,144 1.2%   
Net working cap to sales %33.98.6 392.7%  
Current ratio x2.21.1 188.9%  
Inventory Days Days10491 114.3%  
Debtors Days Days6696 68.7%  
Net fixed assets Rs m20,368495,834 4.1%   
Share capital Rs m2533,737 6.8%   
"Free" reserves Rs m30,9710-   
Net worth Rs m31,2241,686,282 1.9%   
Long term debt Rs m1,409776,221 0.2%   
Total assets Rs m45,5073,469,266 1.3%  
Interest coverage x30.09.8 304.9%   
Debt to equity ratio x00.5 9.8%  
Sales to assets ratio x0.80.4 189.5%   
Return on assets %10.13.6 282.0%  
Return on equity %14.25.6 251.8%  
Return on capital %17.34.9 351.3%  
Exports to sales %45.90-   
Imports to sales %16.60-   
Net fx Rs m11,0420-   
CASH FLOW
From Operations Rs m4,923241,901 2.0%  
From Investments Rs m-1,563-85,715 1.8%  
From Financial Activity Rs m-1,832-290,177 0.6%  
Net Cashflow Rs m1,528-133,991 -1.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 74.73 Rs / USD

Compare IPCA LABS With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare IPCA LABS With: FDC LTD.  BIOCON   WYETH LTD  DISHMAN PHARMA  J.B.CHEMICALS  



Today's Market

Sensex Trades in Green; Bajaj Auto & Bharti Airtel Top Gainers(12:30 pm)

Share markets in India are trading on a positive note in today's volatile trade. Benchmark indices edged higher as positive developments in a coronavirus vaccine trial improved global risk sentiment.

Related Views On News

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY20); Net Profit Up 63.7% (Quarterly Result Update)

Nov 12, 2019 | Updated on Nov 12, 2019

For the quarter ended September 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 63.7% YoY). Sales on the other hand came in at Rs 12 bn (up 21.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

Be Prepared to Profit from the Coming Crash in Oil Prices (Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How... (Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

The Triple Digit Return Opportunity in this Market

Jun 24, 2020

Rahul Shah on stocks with potentially triple digit returns.

This Ratio Says Smallcaps Are Your Best Bet to Ride the Post Covid Market Rebound (Profit Hunter)

Jun 23, 2020

Here's why I believe that post Covid rebound in smallcaps will be much sharper than largecaps.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2020
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

IPCA LABS SHARE PRICE


Jul 3, 2020 02:59 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

FEATURED VIDEOS

MARKET STATS